In ovarian cancer, association of p16 expression with prognosis is different across ovarian carcinoma histological types; absence of p16 expression predicts shorter survival for low-grade serous carcinoma while no survival associations are observed for mucinous carcinomas or high-grade serous carcinomas [11]. The gene discussed is CDKN2A; the disease is ovarian carcinoma.